| |
| |
|
| Insider
Information: |
Henderson Jeffrey William |
| Relationship: |
Director |
| City: |
Dublin |
| State: |
OH |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
155,142 |
|
|
Indirect Shares
|
15 |
|
|
| Direct
Value |
$11,146,027 |
|
|
|
Indirect Value
|
$3,457 |
|
|
| Total
Shares |
155,157 |
|
|
| Total
Value |
$11,149,484 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -36.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cardinal Health Inc |
CAH |
Chief Financial Officer |
2014-08-27 |
67,190 |
2012-09-07 |
0 |
Premium* |
|
|
Halozyme Therapeutics Inc |
HALO |
|
2023-05-05 |
47,110 |
2015-08-05 |
0 |
Premium* |
|
|
QUALCOMM Inc |
QCOM |
Director |
2024-03-10 |
6,408 |
|
0 |
Premium* |
|
|
Fibrogen Inc |
FGEN |
Director |
2023-09-01 |
28,866 |
2018-06-05 |
0 |
Premium* |
|
|
Becton Dickinson & Co |
BDX |
Director |
2024-01-23 |
5,568 |
2024-01-23 |
15 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| QCOM |
QUALCOMM Inc |
Director |
– • – |
2024-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,056 |
6,408 |
0 |
- |
|
| BDX |
Becton Dickinson & Co |
Director |
– • – |
2024-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
900 |
5,568 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2023-09-01 |
4 |
AS |
$1.03 |
$2,060 |
D/D |
(2,000) |
28,866 |
0 |
% |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2023-08-04 |
4 |
AS |
$1.91 |
$3,820 |
D/D |
(2,000) |
30,866 |
0 |
% |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2023-07-11 |
4 |
AS |
$2.69 |
$5,380 |
D/D |
(2,000) |
32,866 |
0 |
% |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2023-06-08 |
4 |
AS |
$16.87 |
$122,185 |
D/D |
(7,000) |
34,866 |
0 |
% |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2023-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
8,289 |
41,866 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
|
– • – |
2023-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
8,065 |
47,110 |
0 |
- |
|
| QCOM |
QUALCOMM Inc |
Director |
– • – |
2023-03-10 |
4 |
D |
$115.19 |
$123,138 |
D/D |
(1,069) |
4,352 |
0 |
- |
|
| QCOM |
QUALCOMM Inc |
Director |
– • – |
2023-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,316 |
5,421 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
|
– • – |
2023-03-01 |
4 |
S |
$47.71 |
$477,100 |
D/D |
(10,000) |
39,045 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
|
– • – |
2023-02-28 |
4 |
S |
$48.51 |
$485,100 |
D/D |
(10,000) |
49,045 |
0 |
% |
|
| QCOM |
QUALCOMM Inc |
Director |
– • – |
2023-02-23 |
4 |
S |
$124.19 |
$310,469 |
D/D |
(2,500) |
2,105 |
0 |
% |
|
| QCOM |
QUALCOMM Inc |
Director |
– • – |
2023-02-22 |
4 |
S |
$124.05 |
$310,132 |
D/D |
(2,500) |
4,605 |
0 |
% |
|
| BDX |
Becton Dickinson & Co |
Director |
– • – |
2023-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
848 |
4,653 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2022-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
15,777 |
33,577 |
0 |
- |
|
| QCOM |
QUALCOMM Inc |
Director |
– • – |
2022-03-12 |
4 |
D |
$152.34 |
$223,787 |
D/D |
(1,469) |
7,105 |
0 |
- |
|
| QCOM |
QUALCOMM Inc |
Director |
– • – |
2022-03-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,559 |
8,574 |
0 |
- |
|
| BDX |
Becton Dickinson & Co |
Director |
– • – |
2022-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
820 |
3,777 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
4,700 |
17,800 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2021-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,230 |
52,839 |
0 |
- |
|
| BDX |
Becton Dickinson & Co |
Director |
– • – |
2021-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
829 |
2,918 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2020-11-25 |
4 |
S |
$40.08 |
$981,757 |
D/D |
(24,498) |
47,609 |
0 |
% |
|
| QCOM |
QUALCOMM Inc |
Director |
– • – |
2020-11-10 |
4 |
S |
$141.10 |
$846,602 |
D/D |
(6,000) |
1,214 |
0 |
% |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2020-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
4,700 |
13,100 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
